The #1 AI-powered therapy

notes – done in seconds

The #1 AI-powered therapy notes – done in seconds

This blog is brought to you by YUNG Sidekick –

the #1 AI-powered therapy notes – done in seconds

This blog is brought to you by YUNG Sidekick — the #1 AI-powered therapy notes – done in seconds

How to Diagnose Recurrent Brief Depression: A Step-by-Step Guide for Clinicians

How to Diagnose Recurrent Brief Depression: A Step-by-Step Guide for Clinicians
How to Diagnose Recurrent Brief Depression: A Step-by-Step Guide for Clinicians
How to Diagnose Recurrent Brief Depression: A Step-by-Step Guide for Clinicians

Dec 12, 2025

Approximately 10% of the general population experiences recurrent brief depression [8]. These episodes last only 3-4 days [8], yet carry a suicide attempt rate of 23.3% [8].

Mental health professionals encounter patients whose depressive symptoms strike with remarkable intensity, then vanish before standard treatments can take hold. These episodes fail to meet the two-week threshold for major depressive disorder, yet they profoundly affect patient mental health, relationships, and daily functioning [9]. The brief but severe nature of these symptoms creates diagnostic puzzles, often leading to misidentification as borderline personality disorder or cyclothymia.

Recurrent brief depression (RBD) presents a clinical paradox. Episodes may be short-lived, but they carry substantial morbidity [3]. Patients endure depressive symptoms that recur frequently over time [9], establishing patterns of distress that require specialized attention. The brevity of these episodes masks their danger—they can precipitate significant suicidal behavior [3], making accurate diagnosis essential.

This guide provides practical tools for recognizing, diagnosing, and managing recurrent brief depression. Understanding RBD's distinct patterns positions you to help patients whose depression operates on an accelerated timeline—brief episodes that demand the same clinical rigor as longer depressive periods. These patients deserve targeted care that matches the unique challenges of their condition.

Understanding the Pattern of Recurrent Brief Depression

Recurrent brief depression presents a mood disturbance pattern that defies conventional diagnostic approaches. Recognizing its distinct characteristics prevents misdiagnosis and ineffective treatment plans for affected patients.

What defines a brief depressive episode

Brief depressive episodes carry the paradox of RBD—intense severity compressed into remarkably short timeframes. Episodes last only 1-3 days (mean duration of 3 days), yet meet full symptomatic criteria for major depression [9]. The brevity masks their clinical significance. Two-thirds of episodes qualify as moderate depression, while one-third reach severe depression levels [9].

Diagnostic criteria require these episodes to occur monthly over 12 months [10]. Episodes follow an average 18-day cycle from onset to onset [9]. Each episode must include five of nine major depressive symptoms plus documented functional impairment [10].

Complete recovery between episodes serves as a critical diagnostic marker. The World Health Organization's ICD-10 criteria (F38.1) specifically require this inter-episode recovery [9]. This complete restoration distinguishes RBD from chronic mood conditions.

How RBD differs from major depression

RBD shares symptom severity with major depressive disorder but diverges in crucial ways. Episode duration falls below the two-week MDD threshold [10]. Yet the distress and impairment during brief episodes can match major depression intensity [10].

Treatment response reveals another key difference. Conventional antidepressants fail to provide benefit since episodes resolve before medication effects begin [9]. Clinical experts emphasize this timing mismatch: "The episodes are too short to be able to assume efficacy with conventional antidepressants; it is necessary to adopt a prophylactic strategy for treatment" [9].

Population studies show RBD affects substantial numbers—one-year prevalence of approximately 5% and lifetime prevalence of 16% [10]. These patients often receive suboptimal care due to misdiagnosis.

Brief hypomania episodes occur in 47% of RBD patients, suggesting bipolar spectrum connections [11]. This comorbidity complicates both diagnostic assessment and treatment selection.

Why timing is the key diagnostic clue

Temporal patterns provide RBD's most reliable diagnostic signature. The unpredictable yet frequent recurrence creates a clinical fingerprint that trained clinicians can identify. Attention to timing prevents common misdiagnoses:

  • Dysthymia or major depression (when patients describe longer continuous periods)

  • Borderline personality disorder (when mood instability overshadows episodic patterns)

  • Premenstrual dysphoric disorder (when episodes coincidentally align with menstrual timing)

Episode tracking becomes essential since RBD follows erratic rather than predictable schedules [9]. Mood calendars maintained over several months reveal the characteristic pattern—brief severe episodes with complete inter-episode recovery.

Combined presentations add diagnostic complexity. Patients with "combined major and recurrent brief depression" experience both conditions simultaneously, leading to increased severity and suicide risk compared to single diagnoses [10]. Recognizing combined patterns directly impacts risk assessment protocols.

The chronic relapsing nature of RBD fundamentally alters treatment approach [9]. Focus shifts from acute episode management to prevention and prophylaxis, addressing the recurring pattern rather than individual episodes.

Differentiating RBD from Similar Disorders

Accurate differential diagnosis prevents ineffective treatments and reduces suicide risk for your patients. Precise attention to symptom patterns and timing distinguishes RBD from conditions that share similar presentations.

Borderline Personality Disorder vs RBD

Emotional instability in BPD often mimics RBD, yet fundamental differences exist between these conditions. BPD depression typically connects directly to interpersonal stress, lifting when relationships stabilize [4]. RBD episodes occur independently of external triggers, following predictable onset and resolution patterns.

Examine the quality of functioning between episodes. BPD patients show persistent emotional regulation difficulties, while RBD patients return to stable baseline functioning with complete recovery. BPD often involves maladaptive self-schemas of the "I am bad" type [4], whereas RBD patients maintain consistent self-perception outside episodes.

Treatment response offers another diagnostic clue. Depression co-occurring with BPD responds poorly to antidepressant medication compared to depression without BPD [4]. When BPD-specific psychotherapy is used, both BPD and depression symptoms improve [5], indicating that BPD drives the depressive symptoms.

Cyclothymia and Bipolar II vs RBD

Cyclothymia involves chronic symptoms of hypomania and depression that remain less severe than major depression or bipolar disorder [6]. Unlike cyclothymia's daily symptoms with few neutral periods [6], RBD features complete recovery between episodes [7].

The "well" periods provide the essential distinction. RBD patients experience true euthymia without hypomanic features. Look for these signs between depressive episodes:

  • Elevated mood or increased energy

  • Decreased need for sleep

  • Racing thoughts or increased goal-directed activity

  • Impulsivity or risk-taking behavior

About 47% of RBD patients report brief episodes of hypomania [7], suggesting overlap with bipolar spectrum disorders. These hypomanic periods in RBD typically last under four days, shorter than the four consecutive days required for bipolar II diagnosis [8].

PMDD vs RBD

Premenstrual Dysphoric Disorder affects 3-8% of women in their reproductive years [9] and can closely resemble RBD. The timing relationship to menstruation provides the crucial difference. PMDD symptoms emerge 1-2 weeks before menses and resolve with menstruation onset [9], creating predictable cycles tied to the menstrual cycle.

Research comparing mood rating patterns found PMDD significantly more regular than RBD [10]. RBD data showed more "staccato" or "spiky" presentations compared to PMDD [10], reflecting the abrupt onset and resolution typical of RBD episodes.

An estimated 40% of women seeking PMDD treatment actually have premenstrual exacerbation of an underlying mood disorder [9]. Look beyond surface mood fluctuations to identify the underlying pattern.

Using the Calendar Method for Clarity

Daily mood tracking over 2-3 months reveals distinctive patterns for each condition. Have patients mark severity on a 0-10 scale to identify:

  • BPD: Mood fluctuations tied to interpersonal events

  • Cyclothymia: Chronic mood swings with few neutral periods

  • PMDD: Symptoms clustered in luteal phase, resolving with menses

  • RBD: Brief, severe episodes with complete recovery between them

Statistical analysis of mood-rating data enhances diagnostic accuracy significantly. Combined criteria based on statistical measures discriminate diagnostic subgroups with high sensitivity and specificity [10].

Instruct patients to track sleep patterns, energy levels, and potential triggers alongside mood. This multi-dimensional approach confirms whether apparent PMDD breaks free of menstrual timing (suggesting RBD), or whether apparent RBD consistently connects to relationship stressors (suggesting BPD).

Step-by-Step Diagnostic Process for Clinicians

Recurrent brief depression diagnosis requires systematic precision. This four-step process provides a reliable framework for identifying this elusive condition in your practice.

Step 1: Take a detailed episode history

Begin with a thorough clinical interview focused on episode patterns. Document these critical elements:

  • Episode duration (typically averaging 3 days) [11]

  • Frequency of occurrences (mean of 14 episodes/year) [11]

  • Complete symptom profile using the SIGECAPS mnemonic: Sleep, Interest, Guilt, Energy, Concentration, Appetite, Psychomotor changes, Suicidal thoughts [1]

  • Inter-episode functioning and recovery status

Gather collateral information from family members or close friends. They often notice functional changes between episodes that patients miss themselves [12]. This outside perspective confirms the episodic nature of symptoms.

Note the age of onset. RBD typically begins around age 20 [11], distinguishing it from mood disorders that emerge later. This early onset helps establish the chronic nature of the condition.

Step 2: Use structured mood tracking tools

Structured tracking reveals patterns that clinical interviews might miss. Consider these approaches:

The PHQ-9 functions as both screening tool and severity tracker [12]. Applied regularly, it captures RBD's distinctive pattern—dramatic spikes followed by complete normalization.

Daily mood charting over 2-3 months using a 0-10 scale provides objective data [13]. Digital options like the DBSA Wellness Tracker monitor mood alongside symptoms, medications, and lifestyle factors [14].

Instruct patients to track:

  • Mood intensity levels

  • Exact episode duration

  • Complete symptom resolution periods

  • Potential triggers or stressors

These tools support diagnosis while establishing treatment monitoring baselines [15].

AI Therapy Notes

Step 3: Rule out comorbid psychiatric conditions

Systematic exclusion prevents misdiagnosis. Start with medical screening—complete blood count, metabolic panel, thyroid function, and toxicology tests [12].

Screen for psychiatric conditions using validated instruments:

  • Mood Disorder Questionnaire for bipolar spectrum disorders [1]

  • Substance use disorder screening

  • Personality disorder assessment, particularly borderline personality disorder

Monitor for brief hypomania. Nearly half of RBD patients experience short hypomanic episodes [11], affecting both treatment selection and prognosis.

Step 4: Confirm episodic pattern over time

Pattern confirmation requires 2-3 months of observation. Establish these criteria:

  1. Monthly episode recurrence over 12 months

  2. Brief duration (1-3 days typically)

  3. Complete inter-episode recovery

  4. Absence of fixed cyclical patterns

The temporal signature distinguishes RBD—two-month periods with minimal symptoms indicate true remission [16]. This confirmation prevents misdiagnosis as dysthymia or partially remitted major depression.

Maintain suicide risk vigilance throughout. RBD episodes correlate with elevated attempt rates, requiring risk assessment at every encounter [12].

Treatment Planning When Episodes Are Short

Standard depression treatments face a fundamental timing problem with RBD episodes. These brief but intense episodes resolve before conventional interventions can take effect, demanding a different therapeutic approach.

Why standard antidepressants may not work

The mismatch between medication timing and episode duration creates the core challenge. Standard antidepressants typically require 4-8 weeks to achieve therapeutic effect [2], while RBD episodes resolve within 1-3 days. Patients return to baseline functioning before medications would begin working.

This timing disconnect leads to frustrating cycles of ineffective medication trials. Adjusting dosages or switching medications becomes pointless when episodes consistently end before the medication's therapeutic window opens.

Research confirms this challenge. Studies examining various antidepressants for RBD—including paroxetine, fluoxetine, flupenthixol, citalopram, and mianserin—show predominantly negative results [3]. The standard depression treatment model simply doesn't align with RBD's compressed timeframe.

The role of long-term prophylaxis

Effective RBD treatment requires shifting from episode management to episode prevention. Prophylactic strategies focus on reducing frequency and severity through continuous medication maintenance during well periods.

Evidence supports this preventative approach. Premature antidepressant discontinuation increases relapse/recurrence risk by 77% [17]. Maintaining medication coverage during asymptomatic periods becomes essential. Standard continuation therapy lasts 4-9 months minimum [17], but RBD may require longer maintenance treatment.

Limited research suggests several prophylactic options:

  • Mood stabilizers, particularly carbamazepine in small studies [3]

  • Higher-dose SSRIs with noradrenergic properties [3]

  • Long-term low-dose antidepressants for prevention

Patient education proves critical here. Adherence during symptom-free periods challenges patients who feel completely recovered.

Crisis rescue strategies for acute episodes

Breakthrough episodes require rapid-response protocols. The National Alliance on Mental Illness notes that "like any other health crisis, it's important to act quickly and effectively in a mental health crisis" [18].

Effective rescue strategies include:

Fast-acting interventions matched to episode duration, such as short-term benzodiazepines for severe anxiety or insomnia. Document rescue plans during well periods for immediate implementation when episodes begin.

Clear crisis communication pathways become vital. Document treatment history and lessons from previous episodes [18]. Create written plans focused on immediate symptom relief rather than long-term stabilization.

Psychotherapy between episodes

Psychotherapy works both independently and alongside medication. For milder depression, therapy often serves as first-line treatment, with medication added if needed [2]. Combined approaches prove more effective than either treatment alone for moderate to severe depression [19].

Cognitive behavioral therapy during well periods builds resilience against future episodes. CBT during medication tapering can decrease relapse risk [19], making it valuable for interrupting recurrent patterns. The therapy's focus on identifying negative thoughts and developing coping strategies particularly benefits patients with predictable episode patterns.

RBD treatment demands a paradigm shift—from episode treatment to episode prevention. Success requires combining prophylactic medication, crisis planning, and inter-episode psychological support.

Managing Suicide Risk in RBD Patients

RBD presents a deceptive suicide risk profile. Episodes may last only days, yet the danger stays substantial. Suicide risk here challenges standard clinical thinking about symptom duration and self-harm potential.

Why suicide risk is high despite short episodes

RBD carries significant elevated risk for suicide attempts [20]. Research shows it may exceed major depression's risk in certain contexts. "Combined depression," where RBD and major depression occur together, represents the strongest clinical predictor of suicide attempts in psychiatric literature [21].

Several factors explain this elevated risk. Depressive symptoms during brief episodes reach severe intensity—matching major depression's magnitude but compressed into days. The recurrent nature creates psychological wear where patients expect future suffering. Episode unpredictability generates anxiety that increases suicidal thoughts.

More than half of all suicide deaths connect to depression [22]. The brief but severe nature of RBD episodes requires careful monitoring. Suicide incidence peaks during the first days after hospital discharge—6062 per 100,000 during days 0-3 [22]. This highlights critical timing considerations in RBD management.

Creating a safety plan during well periods

Safety planning must happen proactively during symptom-free periods. Before episode onset, work with patients to:

  1. Document personal warning signs that precede episodes

  2. Identify coping strategies proven effective previously

  3. Create environmental safety modifications (securing medications, removing potential means)

  4. Establish clear decision trees for escalating care

Create these plans during wellness periods when insight and judgment remain intact [23]. This timing ensures meaningful patient participation before depressive episodes cloud thinking.

Establishing a rapid-response protocol

Quick intervention becomes essential given RBD's compressed timeframe. Design structured protocols that activate immediately when symptoms emerge:

Designated contact person: Establish primary contact Communication pathway: Create direct access bypassing standard scheduling Pre-authorized rescue strategies: Document interventions ready for immediate implementation Emergency service thresholds: Define clear hospitalization criteria

Involving family or support systems

Safety during brief, intense episodes requires support system involvement. Thirty-six percent of primary care clinicians discuss suicide with depressed patients [24]—extend this conversation to family members.

Before episodes begin, educate key support people about symptom recognition. Develop specific roles for them during episodes: medication monitoring, environmental safety checks, transportation assistance [23]. Evidence shows support person intervention can significantly reduce self-harm risk during acute episodes.

RBD suicide risk demands this thorough approach—treating brief episodes with the same seriousness as persistent depression while adapting interventions to their unique timeline.

Monitoring Progress and Adjusting Treatment

RBD management requires consistent monitoring and strategic adjustments. This condition demands attention during both active episodes and quiet periods between symptoms.

Tracking episode frequency and severity

Documentation provides the foundation for effective RBD care. Structured mood tracking tools capture episode frequency and intensity patterns. Weekly PHQ-9 administration reveals the characteristic spikes and complete recovery cycles that define RBD. Digital mood charting applications enable patients to record daily changes, generating useful data for treatment decisions.

Track functional impairment between episodes alongside episode occurrence. Even mild residual depression can significantly affect daily life [25].

When to consider medication changes

Base treatment adjustments on breakthrough episode patterns rather than single incidents. Consider medication modifications when you observe:

  • Multiple breakthrough episodes despite patient adherence

  • Significant side effects that impact quality of life

  • Incomplete recovery between episodes

Premature discontinuation increases relapse risk by 77% [26]. Treatment-resistant cases may benefit from combined psychopharmacology and psychotherapy approaches, which prove more effective than either treatment alone [27].

Using psychotherapy to build resilience

Psychotherapy strengthens patients' ability to withstand future episodes. Cognitive-behavioral therapy delivered between episodes helps develop effective self-management strategies [28].

Target specific resilience areas: self-care practices, self-confidence building, and interpersonal support networks. These domains are essential for sustained recovery [28]. Problem-solving therapy provides active coping skills that counter learned helplessness patterns [29].

Stay focused on prevention rather than crisis response. This approach helps patients develop tools they can use independently when episodes emerge.

Conclusion

Recurrent brief depression challenges conventional psychiatric practice. Episodes lasting 1-3 days match major depression's intensity, carrying elevated suicide risk that demands careful monitoring. Standard diagnostic approaches frequently miss RBD or confuse it with borderline personality disorder, cyclothymia, or PMDD.

Successful diagnosis hinges on recognizing RBD's temporal signature—severe episodes followed by complete recovery. Calendar tracking reveals patterns invisible during standard interviews. Structured mood monitoring tools provide objective evidence for both diagnosis confirmation and treatment tracking.

Traditional antidepressant protocols fail because episodes resolve before medications become effective. Treatment philosophy must shift toward prevention rather than acute response. Maintenance medication during symptom-free periods becomes necessary. Crisis protocols need rapid activation, while inter-episode therapy builds resilience.

Suicide risk demands heightened attention given the compressed episode timeframe. Safety planning during stable periods, emergency response systems, and family involvement create protective networks. This approach treats brief episodes with appropriate seriousness while adapting to their unique timeline.

RBD diagnosis and management requires clinical precision paired with strategic adaptation. Proper recognition and targeted treatment planning substantially improve patient outcomes. Your expertise in pattern identification, preventive strategies, and crisis response directly impacts patients experiencing these recurring but manageable episodes.

Ready to enhance your clinical documentation and patient insights?

Mental health professionals today need tools that match the complexity of conditions like RBD. Session documentation, progress tracking, and treatment planning require precision and efficiency—especially when managing patients with episodic patterns that demand careful monitoring.

Yung Sidekick streamlines your clinical workflow through AI-powered session analysis and automated progress notes. Capture session details effortlessly while maintaining full attention on your patients. Generate comprehensive reports that reveal treatment patterns and patient progress over time.

Start your free trial today

Key Takeaways

Understanding and diagnosing Recurrent Brief Depression requires a fundamental shift from traditional depression treatment approaches, focusing on pattern recognition and preventive strategies rather than acute intervention.

Recognize the temporal signature: RBD episodes last only 1-3 days but occur monthly with complete recovery between episodes, distinguishing it from major depression's 2-week minimum duration.

Use calendar tracking for accurate diagnosis: Implement structured mood tracking over 2-3 months to reveal RBD's distinctive "spiky" pattern and differentiate it from BPD, cyclothymia, or PMDD.

Shift to prophylactic treatment approach: Standard antidepressants fail because episodes resolve before medication takes effect; focus on long-term prevention rather than acute intervention.

Prioritize suicide risk management: Despite brief duration, RBD carries elevated suicide risk requiring safety plans during well periods and rapid-response protocols for breakthrough episodes.

Monitor patterns, not individual episodes: Track episode frequency and severity over time rather than focusing on single occurrences to guide treatment adjustments and medication changes.

The key to successful RBD management lies in recognizing that these brief but intense episodes require the same clinical gravity as persistent depression, while adapting interventions to match their unique compressed timeframe and recurrent nature.

FAQs

What are the key characteristics of Recurrent Brief Depression (RBD)?

RBD is characterized by brief depressive episodes lasting 1-3 days, occurring at least monthly over a 12-month period. These episodes are severe, meeting the symptomatic criteria for major depression, but with complete recovery between episodes.

How does RBD differ from major depressive disorder?

While RBD shares symptom profiles with major depression, RBD episodes fall below the two-week duration threshold required for major depressive disorder diagnosis. RBD also has a distinctive pattern of frequent, brief episodes with full recovery in between.

Why are standard antidepressants often ineffective for treating RBD?

Standard antidepressants typically require 4-8 weeks to achieve therapeutic effect, while RBD episodes resolve spontaneously within 1-3 days. By the time the medication would begin working, the patient has already returned to baseline functioning.

What is the recommended treatment approach for RBD?

Treatment for RBD should focus on prevention rather than acute intervention. This includes long-term prophylactic medication, crisis rescue strategies for breakthrough episodes, and psychotherapy between episodes to build resilience.

Why is suicide risk management crucial in RBD patients?

Despite their brief duration, RBD episodes are associated with a significantly elevated risk of suicide attempts. The intensity of symptoms during these short episodes can be severe, necessitating vigilant monitoring and proactive safety planning.

References

[1] - https://link.springer.com/article/10.1007/BF02190395
[2] - https://www.talktoangel.com/blog/ways-to-overcome-recurrent-brief-depression
[3] - https://pmc.ncbi.nlm.nih.gov/articles/PMC3826008/
[4] - https://pubmed.ncbi.nlm.nih.gov/1308849/
[5] - https://www.psychiatrictimes.com/view/recurrent-brief-mixed-depression
[6] - https://pubmed.ncbi.nlm.nih.gov/8077170/
[7] - https://www.sciencedirect.com/science/article/abs/pii/S0165032710000029
[8] - https://www.sciencedirect.com/science/article/abs/pii/S0165032708001705
[9] - https://www.mja.com.au/journal/2013/199/6/depression-and-borderline-personality-disorder
[10] - https://www.psychologytoday.com/us/blog/the-complex-diagnosis/202205/depression-is-different-in-those-bpd
[11] - https://www.healthline.com/health/bipolar/cyclothymia-vs-bipolar
[12] - https://www.sciencedirect.com/science/article/abs/pii/S0010440X10000180
[13] - https://www.mind.org.uk/information-support/types-of-mental-health-problems/bipolar-disorder/types-of-bipolar/
[14] - https://womensmentalhealth.org/specialty-clinics/pms-and-pmdd/
[15] - https://pubmed.ncbi.nlm.nih.gov/17336329/
[16] - https://www.camh.ca/en/professionals/treating-conditions-and-disorders/depression/depression---screening-and-assessment
[17] - https://www.ncbi.nlm.nih.gov/books/NBK559078/
[18] - https://www.blueprint.ai/blog/mood-charts-in-therapy-a-practical-tool-for-emotional-awareness-tracking-and-insight
[19] - https://www.dbsalliance.org/wellness/wellness-toolbox/wellness-tracker/
[20] - https://pmc.ncbi.nlm.nih.gov/articles/PMC5977660/
[21] - https://www.uptodate.com/contents/approach-to-the-adult-patient-with-suspected-depression
[22] - https://www.nimh.nih.gov/health/publications/depression
[23] - https://jamanetwork.com/journals/jamapsychiatry/fullarticle/204538
[24] - https://www.nami.org/support-education/publications-reports/guides/navigating-a-mental-health-crisis/
[25] - https://www.aafp.org/pubs/afp/issues/2023/0200/pharmacologic-treatment-of-depression.html
[26] - https://pubmed.ncbi.nlm.nih.gov/8775767/
[27] - https://nyaspubs.onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.1997.tb52368.x
[28] - https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2814598
[29] - https://www.naps-rbd.org/blog-1/prioritize-safety-measures-in-rbd-sleeping-environments
[30] - https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults
[31] - https://www.mayoclinic.org/diseases-conditions/persistent-depressive-disorder/diagnosis-treatment/drc-20350935
[32] - https://psychiatryonline.org/doi/10.1176/appi.focus.10.4.434
[33] - https://pmc.ncbi.nlm.nih.gov/articles/PMC8610877/
[34] - https://www.redalyc.org/journal/1806/180674146005/html/
[35] - https://pmc.ncbi.nlm.nih.gov/articles/PMC6732704/

If you’re ready to spend less time on documentation and more on therapy, get started with a free trial today

Not medical advice. For informational use only.

Outline

Title
Title
Title